ANTARES PHARMA INC (AIS) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 106 transactions totaling $520.3K, demonstrating a bearish sentiment with -$186.0K in net insider flow. The most recent transaction on May 30, 2012 involved a sale of 87,500 shares valued at $249.4K.
No significant insider buying has been recorded for AIS in the recent period.
No significant insider selling has been recorded for AIS in the recent period.
Based on recent SEC filings, insider sentiment for AIS is bearish with an Insider Alignment Score of 32/100 and a net flow of -$186.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ANTARES PHARMA INC (AIS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading AIS stock, having executed 106 transactions in the past 90 days. The most active insider is Jacques Gonella (Executive), who has made 4 transactions totaling $1.3M.
Get notified when executives and directors at AIS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 30, 2012 | Gueth Anton | Executive | Sale | 87,500 | $2.85 | $249.4K | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 16,500 | $1.06 | $17.5K | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 195 | $2.90 | $566 | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 500 | $1.13 | $565 | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 2,578 | $2.90 | $7.5K | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 5,750 | $1.30 | $7.5K | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 6,031 | $2.90 | $17.5K | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 2,000 | $1.10 | $2.2K | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 759 | $2.90 | $2.2K | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 2,000 | $1.40 | $2.8K | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 966 | $2.90 | $2.8K | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 500 | $1.32 | $660 | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 228 | $2.90 | $661 | |
| May 29, 2012 | Gueth Anton | Executive | Option Exercise | 2,000 | $1.01 | $2.0K | |
| May 29, 2012 | Gueth Anton | Executive | Payment | 697 | $2.90 | $2.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise (Options)(X) | 3 | $1.3M | 45.9% |
Exercise(M) | 20 | $548.0K | 19.0% |
Payment(F) | 19 | $489.5K | 17.0% |
Sale(S) | 2 | $353.2K | 12.3% |
Purchase(P) | 19 | $167.2K | 5.8% |
Award(A) | 43 | $0 | 0.0% |
Insider selling pressure at ANTARES PHARMA INC has increased, with 12 insiders executing 106 transactions across all time. Total sales of $353.2K significantly outpace purchases of $167.2K, resulting in a net outflow of $186.0K. This selling activity appears largely discretionary, which may warrant closer attention from investors.